Table 1.
Clinical and pathological parameters of CCRCC patients (n = 59).
Fig 1.
FAP immunohistochemical expression in primary and metastatic CCRCC.
Clear cell renal cell carcinoma arranged in nests (A) show FAP-positive cancer-associated fibroblasts delineating tumor lobes (B). Lymph node metastatic tumor growing more diffusely without recognizable architecture (C) displays FAP-positive cancer-associated fibroblasts intimately intermingled with tumor cells (D).
Table 2.
Clinical and pathological variables and FAP expression in primary tumors.
Table 3.
Clinical and pathological variables and FAP expression in metastases.
Fig 2.
Kaplan-Meier survival curves for FAP expression in primary (A) and metastatic (B) clear cell renal cell carcinomas.
10-year overall survival showed significant differences between FAP protein positive and negative cases in primary tumors (log-rank test p<0.05).
Table 4.
Univariate and Multivariate analyses to predict overall survival of mCCRCC patients.